Skip to main content
# Title Department Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
32 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Dr. Marwa Tammam Ameen Hammam 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
34 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
35 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Sanaa Saber Abdelraheem Barakat 2023
36 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
37 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2023
38 Surgical Outcomes of Laparoscopic-assisted Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy Billroth I for Gastric Cancer Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2023
39 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2022
40 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Israa Mostafa Kamal Mohammed 2022